South African doctor says patients with Omicron variant have “very mild” symptoms

JOHANNESBURG – A South African doctor who was one of the first to suspect a different coronavirus strain among patients said on Sunday that symptoms of the Omicron variant were so far mild and could be treated at home.

Dr. Angelique Coetzee, a private practitioner and chair of South African Medical Association, told Reuters that on Nov. 18 she noticed seven patients at her clinic who had symptoms different from the dominant Delta variant, albeit “very mild.”

Now designated Omicron by the World Health Organization, the variant was detected and announced by South Africa’s National Institute of Communicable Diseases (NICD) on Nov. 25 from samples taken from a laboratory from Nov. 14 to Nov. 16.

Coetzee said a patient on Nov. 18 reported at her clinic being “extremely fatigued” for two days with body aches and headache.

“Symptoms at that stage was very much related to normal viral infection. And because we haven’t seen COVID-19 for the past eight to 10 weeks, we decided to test,” she said, adding that the patient and his family turned out to be positive.

On the same day, more patients came in with similar symptoms, which was when she realized there was “something else going on.” Since then, she’s seen two to three patients a day.

“We have seen a lot of Delta patients during the third wave. And this doesn’t fit in the clinical picture,” she said, adding she alerted NICD on the same day with the clinical results.

“Most of them are seeing very, very mild symptoms and none of them so far have admitted patients to surgeries. We have been able to treat these patients conservatively at home,” she said.

A healthcare worker collects a swab from a passenger for a PCR test before traveling to Uganda, amidst the spread of the new SARS-CoV-2 variant Omicron, at O.R. Tambo International Airport in Johannesburg.REUTERS/ Sumaya Hisham

Coetzee, who is also on the Ministerial Advisory Committee on Vaccines, said unlike the Delta so far patients have not reported loss of smell or taste and there has been no major drop in oxygen levels with the new variant.

Her experience so far has been that the variant is affecting people who are 40 or younger. Almost half of the patients with Omicron symptoms that she treated were not vaccinated.

“The most predominant clinical complaint is severe fatigue for one or two days. With them, the headache and the body aches and pain.”

The news of the new variant emerging from South Africa prompted a swift reaction from several countries, including Britain, which on Friday imposed a travel ban on several southern African countries with immediate effect, a decision South Africa has strongly contested.

Since Friday, many countries have also banned air travel to and from South Africa, including the United States, other European countries, and some Asian nations.

Reuters

Recent Posts

Love Your Park Week offers over 100 ways to help and explore Philly parks

It's that time of year again to show some endearment to the city and its…

4 hours ago

Homeless services budget hearing touches on Kensington sweep, new ‘wellness’ center

Representatives from the Office of Homeless Services were back before City Council on Monday, trying…

4 hours ago

Pennsylvania nurse who gave patients lethal or possibly lethal insulin doses gets life in prison

By BRUCE SHIPKOWSKI Associated Press A Pennsylvania nurse who administered lethal or potentially lethal doses…

4 hours ago

Where to nab your local Mother’s Day gifts in Philadelphia

Looking to surprise and celebrate that special lady in your life? Here are where to…

5 hours ago

Philadelphia choses the ‘Italian’ as it’s favorite hoagie according to Metro poll

National Hoagie Day has now come and gone, and as folks around the country enjoyed…

6 hours ago

Daryl Morey is ‘excited to attack’ offseason; hopes to begin new era of continuity

Philadelphia 76ers president of basketball operations Daryl Morey addressed the media Monday afternoon from the…

8 hours ago

This website uses cookies.